“Under this manufacturing autohorization, the company’s oral solid dosage manufacturing facility and oncology facility in Baddi, Himachal Pradesh have been certified as complying with the Good Manufacturing Practices (GMP),” Panacea Biotec said in a press release.
The 22 products under approval are in various therapeutic categories including organ transplantation, diabetes management, oncology, piles management, pain management and gastroenterology etc. Both the oral solid dosage manufacturing facility and oncology facility were inspected by the auditors from state service of Ukraine on medicines and drugs control during the period from 19.06.2017 to 24.06.2017, it added.
At 12:34 PM; the stock was up 9% at Rs 246 on the NSE as compared to 0.05% decline in the Nifty50 index. A combined 707,441 shares changed hands on the counter on the NSE and BSE so far.